# Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants

> **NCT01783041** · PHASE2,PHASE3 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 144 (actual)

## Conditions studied

- Prematurity
- Neurodevelopmental Disorder
- Carnitine Deficiency

## Interventions

- **DRUG:** L-carnitine
- **DRUG:** 5% Dextrose

## Key facts

- **NCT ID:** NCT01783041
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2020-12
- **Final completion:** 2021-12-28
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2023-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01783041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01783041, "Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01783041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*